Literature DB >> 22584061

Islet engraftment and revascularization in clinical and experimental transplantation.

Christian Molnár1, Magnus Essand, Lars Wennberg, Christian Berne, Erik Larsson, Gunnar Tufveson, Olle Korsgren.   

Abstract

Proper revascularization after transplantation is assumed to be crucial for appropriate islet graft function. We developed a novel noninvasive imaging method, based on adenoviral transduction of islets with a hypoxia responsive reporter gene, for continuous in vivo monitoring of hypoxia in islet grafts in a mouse model. In addition, morphological data were obtained from a deceased patient previously subject to intraportal transplantation. We detected only transient hypoxia in a minority of the animals transplanted. Importantly, a clear response to hypoxia was observed in vitro after removal of the islet grafts on day 28 after transplantation. Also, the morphological data from the deceased patient demonstrated an extensive revascularization of the transplanted islets. In fact, no differences could be seen between native islets, in pancreas biopsies taken prior to islet isolation, and transplanted islets regarding the number, distribution, and shape of the blood vessels. However, fewer small islets (diameter <39 µm) were found in the liver compared to those found in native pancreases. Notably, an absolute majority of the transplanted islets were found remaining within the venous lumen, in direct contact with the vessel wall. In conclusion, the results presented show less pronounced islet graft hypoxia after subcapsular transplantation than previously reported using more invasive methods. Also, formation of an extensive intraislet capillary network, similar to that seen in native islets in the pancreas, was seen after clinical islet transplantation.

Entities:  

Mesh:

Year:  2012        PMID: 22584061     DOI: 10.3727/096368912X640637

Source DB:  PubMed          Journal:  Cell Transplant        ISSN: 0963-6897            Impact factor:   4.064


  7 in total

1.  Intrapleural transplantation of allogeneic pancreatic islets achieves glycemic control in a diabetic non-human primate.

Authors:  Ji Lei; Alexander Zhang; Hongping Deng; Zhihong Yang; Cole W Peters; Kang M Lee; Zhenjuan Wang; Ivy A Rosales; Charles G Rickert; James F Markmann
Journal:  Am J Transplant       Date:  2021-11-15       Impact factor: 8.086

Review 2.  Islet cell transplant and the incorporation of Tregs.

Authors:  Adam Krzystyniak; Karolina Gołąb; Piotr Witkowski; Piotr Trzonkowski
Journal:  Curr Opin Organ Transplant       Date:  2014-12       Impact factor: 2.640

3.  Synergic effects of oxygen supply and antioxidants on pancreatic β-cell spheroids.

Authors:  Dina Myasnikova; Tatsuya Osaki; Kisaki Onishi; Tatsuto Kageyama; Binbin Zhang Molino; Junji Fukuda
Journal:  Sci Rep       Date:  2019-02-12       Impact factor: 4.379

4.  Adenovirus serotype 5 vectors with Tat-PTD modified hexon and serotype 35 fiber show greatly enhanced transduction capacity of primary cell cultures.

Authors:  Di Yu; Chuan Jin; Mohanraj Ramachandran; Jing Xu; Berith Nilsson; Olle Korsgren; Katarina Le Blanc; Lene Uhrbom; Karin Forsberg-Nilsson; Bengt Westermark; Rachel Adamson; Norman Maitland; Xiaolong Fan; Magnus Essand
Journal:  PLoS One       Date:  2013-01-25       Impact factor: 3.240

Review 5.  Revascularization of transplanted pancreatic islets and role of the transplantation site.

Authors:  Andrew R Pepper; Boris Gala-Lopez; Oliver Ziff; A M James Shapiro
Journal:  Clin Dev Immunol       Date:  2013-09-09

Review 6.  A Deeper Look into Type 1 Diabetes - Imaging Immune Responses during Onset of Disease.

Authors:  Gustaf Christoffersson; Matthias G von Herrath
Journal:  Front Immunol       Date:  2016-08-15       Impact factor: 7.561

7.  Integrated whole liver histologic analysis of the allogeneic islet distribution and characteristics in a nonhuman primate model.

Authors:  Geun Soo Kim; Jong Hyun Lee; Du Yeon Shin; Han Sin Lee; Hyojun Park; Kyo Won Lee; Heung-Mo Yang; Sung Joo Kim; Jae Berm Park
Journal:  Sci Rep       Date:  2020-01-21       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.